# Delayed Start Versus Conventional Antagonist Protocol in Poor Responders Pretreated by Estradiol in Luteal Phase

> **NCT02333253** · PHASE3 · COMPLETED · sponsor: **Cairo University** · enrollment: 60 (actual)

## Conditions studied

- Other Complications Associated With Artificial Fertilization

## Interventions

- **DRUG:** cetrotide

## Key facts

- **NCT ID:** NCT02333253
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2016-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02333253

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02333253, "Delayed Start Versus Conventional Antagonist Protocol in Poor Responders Pretreated by Estradiol in Luteal Phase". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02333253. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
